Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sagimet Biosciences (SGMT) Cash from Financing Activities: 2022-2024

Historic Cash from Financing Activities for Sagimet Biosciences (SGMT) over the last 3 years, with Dec 2024 value amounting to $104.8 million.

  • Sagimet Biosciences' Cash from Financing Activities rose 97.03% to -$27,000 in Q2 2024 from the same period last year, while for Jun 2024 it was $191.1 million, marking a year-over-year change of. This contributed to the annual value of $104.8 million for FY2024, which is 21.65% up from last year.
  • As of FY2024, Sagimet Biosciences' Cash from Financing Activities stood at $104.8 million, which was up 21.65% from $86.2 million recorded in FY2023.
  • In the past 5 years, Sagimet Biosciences' Cash from Financing Activities ranged from a high of $104.8 million in FY2024 and a low of -$73,000 during FY2022.
  • Moreover, its 3-year median value for Cash from Financing Activities was $86.2 million (2023), whereas its average is $63.6 million.
  • Data for Sagimet Biosciences' Cash from Financing Activities shows a peak YoY spiked of 118,136.99% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Sagimet Biosciences' Cash from Financing Activities stood at -$73,000 in 2022, then skyrocketed by 118,136.99% to $86.2 million in 2023, then rose by 21.65% to $104.8 million in 2024.